CDK4/6-Based Drug Research and Development: A Four-Year Update
{{output}}
Introduction: CDK4/6 kinases are crucial cell cycle regulators, and pharmacological inhibition of these kinases to block the G1-to-S phase transition has become an integral part of modern cancer therapy. Although five CDK4/6 inhi... ...
